News Med comms agency 90TEN acquired by Envision Pharma Group 90TEN has been acquired by Envision Pharma Group in a move its new parent company says will deepen and diversify its offering.
News Envision Pharma Group appoints David Thompson as CEO Scientific communications organisation the Envision Pharma Group has revamped its top team, promoting David Thompson to chief executive officer as Brian Hepburn shifts to become its executi
News Envision Pharma Group relocates to larger US offices Envision Pharma Group has opened two new East Coast offices as it seeks larger premises for its New Jersey and Connecticut teams.
News Envision appoints Amanda Boughey to patient partner role Envision Pharma Group has expanded its Envision the Patient team with the appointment of Amanda Boughey as global patient partnership director.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
